ADURO BIOTECH, INC.·4

Feb 12, 8:10 PM ET

Templeman Blaine 4

4 · ADURO BIOTECH, INC. · Filed Feb 12, 2018

Insider Transaction Report

Form 4
Period: 2018-02-08
Templeman Blaine
Executive VP, General Counsel
Transactions
  • Award

    Stock Option (right to buy)

    2018-02-28+155,000155,000 total
    Exercise: $6.05Exp: 2028-02-07Common Stock (155,000 underlying)
Footnotes (1)
  • [F1]The shares subject to the Option vest in 48 equal monthly installments from the vesting commencement date of February 8, 2018.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION